دورية أكاديمية
Avapritinib is effective for treatment of minimal residual disease in acute myeloid leukemia with t (8;21) and kit mutation failing to immunotherapy after allogeneic hematopoietic stem cell transplantation
| العنوان: | Avapritinib is effective for treatment of minimal residual disease in acute myeloid leukemia with t (8;21) and kit mutation failing to immunotherapy after allogeneic hematopoietic stem cell transplantation |
|---|---|
| المؤلفون: | Kong, JunAff1, Aff2, Aff3, Zheng, Feng-MeiAff1, Aff2, Aff3, Wang, Zhi-DongAff1, Aff2, Aff3, Zhang, Yuan-YuanAff1, Aff2, Aff3, Cheng, Yi-FeiAff1, Aff2, Aff3, Fu, Hai-XiaAff1, Aff2, Aff3, Lv, MengAff1, Aff2, Aff3, Chen, HuanAff1, Aff2, Aff3, Xu, Lan-PingAff1, Aff2, Aff3, Zhang, Xiao-HuiAff1, Aff2, Aff3, Huang, Xiao-JunAff1, Aff2, Aff3, Aff4, Wang, YuAff1, Aff2, Aff3, IDs4140902301973x_cor12 |
| المصدر: | Bone Marrow Transplantation: Official journal of the European Society for Blood and Marrow Transplantation. 58(7):777-783 |
| قاعدة البيانات: | Springer Nature Journals |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 02683369 14765365 |
|---|---|
| DOI: | 10.1038/s41409-023-01973-x |